Regulation of cleavage embryo genes upon DRP1 inhibition in mouse embryonic stem cells

The ELSAH (electronic smart patch system for wireless monitoring of molecular biomarkers for healthcare and wellbeing) project has received funding from EU's Horizon 2020 research and innovation program (grant agreement no. 825549). Its aim is to develop a wearable smart patch-based microneedle sensor system that can simultaneously measure several biomarkers in users' dermal interstitial fluid. This system could have several use cases based on continuous glucose and lactate monitoring: early detection of (pre-) diabetes mellitus, increasing physical performance through optimal carbohydrate intake, achieving a healthier lifestyle through behavioral changes based on the interpretation of glucose data, performance diagnostics (lactate threshold test), control of optimal training intensities corresponding with certain lactate levels, or warning of diseases/health threats, such as the metabolic syndrome or sepsis associated with increased lactate levels. The ELSAH patch system has a high potential of increasing health and wellbeing in users.

Automated summary

The ELSAH project, funded by EU's Horizon 2020 program, aims to develop a wearable smart patch system that can measure multiple biomarkers in users' dermal interstitial fluid. This system has various use cases, including early detection of diabetes, improving physical performance, promoting a healthier lifestyle, performance diagnostics, and warning of health threats. The ELSAH patch system has great potential in enhancing health and wellbeing in users.